Yeoju-gun, South Korea

Ji Sook Kim

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2012 - 2014)
  • Yeoju-gun, KR (2012 - 2014)
  • Yongin-si, KR (2017)
  • Hwaseong-si, KR (2020 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Ji Sook Kim: Innovator in Pharmaceutical Composition

Introduction

Ji Sook Kim is a prominent inventor based in Yeoju-gun, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of acute myeloid leukemia and various cancers. With a total of 12 patents to his name, his work continues to impact the medical community.

Latest Patents

Among his latest patents is a pharmaceutical composition comprising a FLT3 inhibitor and a hypomethylating agent for treating acute myeloid leukemia. This innovative composition is designed to provide a therapeutically effective combination for patients suffering from AML. Another notable patent involves pyrimidine compounds and pharmaceutical compositions aimed at preventing or treating cancers, showcasing his commitment to advancing cancer treatment.

Career Highlights

Ji Sook Kim has worked with reputable companies such as Hanmi Pharm. Co., Ltd. and Hanmi Science. His experience in these organizations has allowed him to develop groundbreaking pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Ji Sook Kim has collaborated with esteemed colleagues, including Young Gil Ahn and In Hwan Bae. These partnerships have fostered an environment of innovation and creativity in the pharmaceutical field.

Conclusion

Ji Sook Kim's contributions to pharmaceutical innovation are noteworthy and continue to influence the treatment of serious health conditions. His dedication to research and development exemplifies the spirit of innovation in the medical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…